Personal information

No personal information available

Activities

Collapse all

Works (5)

In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells

JCI Insight
2022-11-08 | Journal article
DOI: 10.1172/jci.insight.161698
Contributors: Kim Anthony-Gonda; Alex Ray; Hang Su; Yuge Wang; Ying Xiong; Danica Lee; Ariele Block; Vanessa Chilunda; Jessica Weiselberg; Lily Zemelko et al.
Source: check_circle
Crossref

Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.

BMC medical ethics
2022-04-09 | Journal article
DOI: 10.1186/s12910-022-00780-1
PMID: 35397551
PMC: PMC8994300
Contributors: Kim Anthony-Gonda
Source: Self-asserted source
Kim Anthony-Gonda

Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models

Science Translational Medicine
2021-03-24 | Journal article
DOI: 10.1126/scitranslmed.abc6401
Contributors: Dina Schneider; Ying Xiong; Darong Wu; Peirong Hu; Leah Alabanza; Brittany Steimle; Hasan Mahmud; Kim Anthony-Gonda; Winfried Krueger; Zhongyu Zhu et al.
Source: check_circle
Crossref

Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model

Science Translational Medicine
2019-08-07 | Journal article
DOI: 10.1126/scitranslmed.aav5685
Contributors: Kim Anthony-Gonda; Ariola Bardhi; Alex Ray; Nina Flerin; Mengyan Li; Weizao Chen; Christina Ochsenbauer; John C. Kappes; Winfried Krueger; Andrew Worden et al.
Source: check_circle
Crossref

Activation of silenced cytokine gene promoters by the synergistic effect of TBP-TALE and VP64-TALE activators.

PloS one
2014-04-22 | Journal article
DOI: 10.1371/journal.pone.0095790
PMID: 24755922
PMC: PMC3995891
Contributors: Kim Anthony-Gonda
Source: Self-asserted source
Kim Anthony-Gonda
How many people are using ORCID?